BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15001534)

  • 1. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis.
    Shimada K; Matsuyoshi S; Nakamura M; Ishida E; Kishi M; Konishi N
    Carcinogenesis; 2004 Jul; 25(7):1089-97. PubMed ID: 15001534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Prostate; 2003 Jun; 55(4):265-80. PubMed ID: 12712406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Jpn J Cancer Res; 2002 Oct; 93(10):1164-74. PubMed ID: 12417047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells.
    Shiah SG; Chuang SE; Kuo ML
    Mol Pharmacol; 2001 Feb; 59(2):254-62. PubMed ID: 11160861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
    Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
    Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FADD phosphorylation is critical for cell cycle regulation in breast cancer cells.
    Matsuyoshi S; Shimada K; Nakamura M; Ishida E; Konishi N
    Br J Cancer; 2006 Feb; 94(4):532-9. PubMed ID: 16450001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Jun NH2-terminal kinase activation leads to a FADD-dependent but Fas ligand-independent cell death in Jurkat T cells.
    Chen Y; Lai MZ
    J Biol Chem; 2001 Mar; 276(11):8350-7. PubMed ID: 11106658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
    Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
    Hu H; Jiang C; Ip C; Rustum YM; Lü J
    Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.
    Widmann C; Johnson NL; Gardner AM; Smith RJ; Johnson GL
    Oncogene; 1997 Nov; 15(20):2439-47. PubMed ID: 9395240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase pathway.
    Ikeda A; Hasegawa K; Masaki M; Moriguchi T; Nishida E; Kozutsumi Y; Oka S; Kawasaki T
    J Biochem; 2001 Dec; 130(6):773-81. PubMed ID: 11726277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines.
    Mabuchi S; Ohmichi M; Kimura A; Nishio Y; Arimoto-Ishida E; Yada-Hashimoto N; Tasaka K; Murata Y
    Endocrinology; 2004 Jan; 145(1):49-58. PubMed ID: 14500571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.
    Hofmann TG; Stollberg N; Schmitz ML; Will H
    Cancer Res; 2003 Dec; 63(23):8271-7. PubMed ID: 14678985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor.
    Zhu N; Ware CF; Lai MM
    Virology; 2001 May; 283(2):178-87. PubMed ID: 11336543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis.
    Chen CY; Juo P; Liou JS; Li CQ; Yu Q; Blenis J; Faller DV
    Cell Growth Differ; 2001 Jun; 12(6):297-306. PubMed ID: 11432804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
    Xiao D; Choi S; Johnson DE; Vogel VG; Johnson CS; Trump DL; Lee YJ; Singh SV
    Oncogene; 2004 Jul; 23(33):5594-606. PubMed ID: 15184882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.
    Yamamoto K; Ichijo H; Korsmeyer SJ
    Mol Cell Biol; 1999 Dec; 19(12):8469-78. PubMed ID: 10567572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.